Submitted by Anonymous (not verified) on 19 September 2024 - 11:47
Opinion/decision on a Paediatric investigation plan (PIP): Tavneos, Avacopan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Immunology-Rheumatology-Transplantation, PIP number: P/0352/2023
Source: